高级检索
当前位置: 首页 > 详情页

Inhibitory Effect of Cinobufagin on L-Type Ca2+ Currents, Contractility, and Ca2+ Homeostasis of Isolated Adult Rat Ventricular Myocytes

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Hebei Medical University, 361 East Zhongshan Road, Shijiazhuang, Hebei 050017, China [2]The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050011, China [3]Department of Pharmacology, Hebei University of Chinese Medicine, Shijiazhuang, Hebei 050200, China
出处:
ISSN:

摘要:
Cinobufagin (CBG), a major bioactive ingredient of the bufanolide steroid compounds of Chan Su, has been widely used to treat coronary heart disease. At present, the effect of CBG on the L-type Ca2+ current (ICa-L) of ventricular myocytes remains undefined. The aim of the present study was to characterize the effect of CBG on intracellular Ca2+ ([Ca2+](i)) handling and cell contractility in rat ventricular myocytes. CBG was investigated by determining its influence on ICa-L, Ca2+ transient, and contractility in rat ventricular myocytes using the whole-cell patch-clamp technique and video-based edge-detection and dual-excitation fluorescence photomultiplier systems. The dose of CBG (10(-8) M) decreased the maximal inhibition of CBG by 47.93%. CBG reduced ICa-L in a concentration-dependent manner with an IC50 of 4 x 10(-10) M, up shifted the current-voltage curve of ICa-L, and shifted the activation and inactivation curves of ICa-L leftward. Moreover, CBG diminished the amplitude of the cell shortening and Ca2+ transients with a decrease in the time to peak (Tp) and the time to 50% of the baseline (Tr). CBG inhibited L-type Ca2+ channels, and reduced [Ca2+](i) and contractility in adult rat ventricular myocytes. These findings contribute to the understanding of the cardioprotective efficacy of CBG.

基金:

基金编号: 10276105D-2 C 2011206025 H 2014206244

语种:
被引次数:
WOS:
PubmedID:
中科院分区:
出版当年[2014]版:
大类 | 3 区 综合性期刊
小类 | 3 区 综合性期刊
最新[2025]版:

影响因子: 最新[2023版] 最新五年平均 出版当年[2014版] 出版当年五年平均 出版前一年[2013版]

第一作者:
第一作者机构: [1]Hebei Medical University, 361 East Zhongshan Road, Shijiazhuang, Hebei 050017, China
共同第一作者:
通讯作者:
通讯机构: [1]Hebei Medical University, 361 East Zhongshan Road, Shijiazhuang, Hebei 050017, China [3]Department of Pharmacology, Hebei University of Chinese Medicine, Shijiazhuang, Hebei 050200, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:39770 今日访问量:0 总访问量:1333 更新日期:2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 河北医科大学第四医院 技术支持:重庆聚合科技有限公司 地址:河北省石家庄市健康路12号